Status:

ACTIVE_NOT_RECRUITING

Automated Vision Assessment and Impairment Detection Through Gaze Analysis in Wet AMD Patients

Lead Sponsor:

Tan Tock Seng Hospital

Collaborating Sponsors:

Occutrack Medical Solutions Pte Ltd

Conditions:

Age-Related Macular Degeneration

Wet Age-related Macular Degeneration

Eligibility:

All Genders

55+ years

Brief Summary

The study aims to evaluate the Automated Vision Assessment and Impairment Detection through Gaze Analysis (AVIGA) system in the ability to detect and assess central vision dysfunction in a personalize...

Detailed Description

Macula degeneration is more prevalent with ageing and can result in blurred or distorted vision, often accompanied by a dark patch blocking the center of the visual field. In the management of age-rel...

Eligibility Criteria

Inclusion

  • Subjects in the age group = 55 years and above.
  • Both genders
  • Subjects with Wet-AMD
  • Ability to comply with the study protocol, in the investigator\'s judgment
  • Subjects must be able to understand and provide informed consent. A signed informed consent form must be provided before any study assessments are done.

Exclusion

  • Uncontrolled blood pressure, defined as systolic blood pressure \>180 millimeters of mercury (mmHg) and/or diastolic blood pressure \>100 mmHg while a patient is at rest.
  • Any history of macular pathology unrelated to AMD affecting vision or contributing to the presence of intraretinal or subretinal fluid in the study eye
  • Any concurrent intraocular condition in the study eye that, in the opinion of the investigator, could either reduce the potential for visual improvement or require medical or surgical intervention during the study
  • History of idiopathic or autoimmune-associated uveitis in either eye
  • Active ocular inflammation or suspected or active ocular or periocular infection in either eye
  • Other protocol-specified exclusion criteria may apply

Key Trial Info

Start Date :

April 18 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

128 Patients enrolled

Trial Details

Trial ID

NCT06518512

Start Date

April 18 2023

End Date

December 1 2026

Last Update

January 8 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tan Tock Seng Hospital

Singapore, Singapore, 308433